Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
Jing Yang, Yanping Gong, Shuping Yan, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 44-57
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Update on Fundamental Mechanisms of Thyroid Cancer
Alessandro Prete, Patricia Borges de Souza, Simona Censi, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 365
NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis
Barbora Pekova, Vlasta Sýkorová, Karolina Mastnikova, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1932-1932
Open Access | Times Cited: 80
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
Jinwei Hu, Isabella J. Yuan, Saied Mirshahidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1950-1950
Open Access | Times Cited: 69
Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations
Aline Rangel‐Pozzo, Luiza Sisdelli, Maria Isabel V. Cordioli, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3146-3146
Open Access | Times Cited: 53
Molecular Markers Guiding Thyroid Cancer Management
Carolina Nylén, Robert Mechera, Isabella Maréchal-Ross, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2164-2164
Open Access | Times Cited: 51
The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy
Amandeep Singh, Jeehoon Ham, Joseph W. Po, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1082-1082
Open Access | Times Cited: 51
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
Heera Yang, Hyunju Park, Hyun Jin Ryu, et al.
Endocrinology and Metabolism (2022) Vol. 37, Iss. 4, pp. 652-663
Open Access | Times Cited: 30
The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta‐analysis
Bojie Chen, Yuan Shi, Yanan Xu, et al.
Clinical Endocrinology (2020) Vol. 94, Iss. 5, pp. 731-742
Open Access | Times Cited: 42
2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules
Young Joo Park, Eun Kyung Lee, Young Shin Song, et al.
International Journal of Thyroidology (2023) Vol. 16, Iss. 1, pp. 1-31
Open Access | Times Cited: 16
Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
Paula Soares, Antónia Póvoa, Miguel Melo, et al.
Endocrine Pathology (2021) Vol. 32, Iss. 1, pp. 44-62
Closed Access | Times Cited: 28
Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma
Ana Stosic, Fabio Fuligni, Nathaniel D. Anderson, et al.
Cancer Research (2021) Vol. 81, Iss. 22, pp. 5625-5637
Open Access | Times Cited: 28
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer
Ye Sang, Guanghui Hu, Junyu Xue, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 304-312
Closed Access | Times Cited: 4
Estudio de la mutación C228T del promotor de TERT en punciones aspirativas tiroideas de la categoría IV de la clasificación de Bethesda
Berta Bella Burgos, Ruben Carrera Salas, Ricard Onieva Carbajo, et al.
Endocrinología Diabetes y Nutrición (2025), pp. 501564-501564
Closed Access
Prediction of BRAF and TERT status in PTCs by machine learning-based ultrasound radiomics methods: A multicenter study
Hui Shi, Ke Ding, Xiuyan Yang, et al.
Journal of Clinical & Translational Endocrinology (2025), pp. 100390-100390
Open Access
Associations of clinicopathologic features and mutation status with lateral lymph node metastasis as a predictor of disease-free survival in papillary thyroid carcinoma
Van Phu Thang Nguyen, Hirokazu Kurohama, Yuko Akazawa, et al.
Pathology - Research and Practice (2025), pp. 155951-155951
Open Access
Association of TERT promoter mutation with oral squamous cell carcinoma: a systematic review and meta-analysis
Monal Yuwanati, Sachin C. Sarode, Gargi S. Sarode, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
Sue Youn Kim, Tae‐Eun Kim, Kwangsoon Kim, et al.
Journal of Pathology and Translational Medicine (2020) Vol. 54, Iss. 4, pp. 310-317
Open Access | Times Cited: 31
Genetics and Epigenetics of Sex Bias: Insights from Human Cancer and Autoimmunity
Sara Carmela Credendino, Christoph Neumayer, Irene Cantone
Trends in Genetics (2020) Vol. 36, Iss. 9, pp. 650-663
Closed Access | Times Cited: 28
Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma
Jeonghun Lee, Eun Ju Ha, Jin Roh, et al.
Surgery (2021) Vol. 170, Iss. 3, pp. 743-747
Closed Access | Times Cited: 27
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
Antónia Póvoa, Elisabete Teixeira, María Rosa Bella, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2048-2048
Open Access | Times Cited: 27
Sex disparities in thyroid cancer: a SEER population study
Peng Li, Ying Ding, Mengyuan Liu, et al.
Gland Surgery (2021) Vol. 10, Iss. 12, pp. 3200-3210
Open Access | Times Cited: 25
Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status
Hyunju Park, Jung Heo, Chang‐Seok Ki, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 5, pp. 2916-2925
Open Access | Times Cited: 9
Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation
Myoung Kyoung Kim, Hyunju Park, Young Lyun Oh, et al.
Korean Journal of Radiology (2024) Vol. 25, Iss. 1, pp. 103-103
Open Access | Times Cited: 3
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024
Eun Kyung Lee, Young Shin Song, Ho‐Cheol Kang, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 68-96
Open Access | Times Cited: 3
TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
Min Jhi Kim, Jin Kyong Kim, Gi Jeong Kim, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4928-4928
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top